Floatz logo

Nbm-Bmx

Eye Cancer, Intraocular Melanoma

Novelwise Pharmaceutical CorporationPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Eye Cancer, Intraocular Melanoma cohort.

Asset / SponsorPhaseRating
MELATONIN
Gustav Stalhammar
Phase 3B

Same molecule, other indications

Nbm-Bmx is also rated in:

cancerDormant
B
Indicative ·
57 / 100
View asset →
ocular cancerDormant
CCC
Indicative ·
48 / 100
View asset →
uveal melanomaDormant
CC
Indicative ·
45 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →